• AMYLIN PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: AMLN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.750 Hold 20
    30 Days Ago 2.895 Hold 19
    60 Days Ago 2.895 Hold 19
    90 Days Ago 2.818 Hold 22
    120 Days Ago 2.783 Hold 23

  • Analyst Ratings: AMLN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Canaccord Adams Sell Hold 10/07/2008 —
    Citigroup Sell Hold 10/05/2008 17.00
    Leerink Swann — Outperform 10/03/2008 34.00
    Collins Stewart — Hold 09/26/2008 —
    Lazard Capital Hold Buy 09/02/2008 —
    Canaccord Adams — Sell 08/27/2008 20.00
    Lehman Brothers — Equal-Weight 08/27/2008 23.00
    Robert W. Baird Outperform Neutral 08/27/2008 27.00
    Soleil Hold Sell 08/27/2008 —
    Leerink Swann — Outperform 08/25/2008 —
    Stanford Research Buy Hold 08/19/2008 33.00
    Friedman Billings Outperform — 07/10/2008 —
    Friedman Billings Outperform — 06/30/2008 —
    Jefferies & Co Buy Hold 06/09/2008 33.00
    Lehman Brothers Underweight Equal-Weight 05/28/2008 31.00
    BMO Capital Markets Market Perform Underperform 04/22/2008 —
    Lehman Brothers — Underperform 04/22/2008 23.00
    Lazard Capital Buy Hold 03/03/2008 —
    Canaccord Adams — Sell 02/12/2008 —
    Stanford Research — Buy 01/29/2008 49.00
    Lazard Capital — Buy 01/29/2008 57.00
    BMO Capital Markets — Market Perform 01/29/2008 34.00
    Friedman Billings — Outperform 01/29/2008 43.00
    Robert W. Baird — Outperform 01/15/2008 47.00
    Friedman Billings — Outperform 01/04/2008 46.00
    Friedman Billings — Outperform 11/29/2007 58.00
    JP Morgan — Neutral 11/09/2007 —
    Lehman Brothers Equal-weight Underweight 11/01/2007 —
    Rodman & Renshaw Mkt Outperform Mkt Perform 10/31/2007 —
    BMO Capital Markets — Market Perform 10/18/2007 44.00
    Next